Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial.

Overview
Research
Identity
Additional Document Info
View All

authors

Bhagat, Naveen
De, Arka
Duseja, Ajay
C P, Ganesh
Manish Kumar, MD
Mehta, Manu
Taneja, Sunil
Sahni, Nancy
Singh, Virendra

publication date

April 2026

published in

The Indian journal of medical research Journal

has subject area